Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%
Programmed Cell Death
83%
Histone Deacetylase Inhibitor
50%
Dynamin
50%
Cytotoxicity
33%
Caspase
33%
Death Receptor
33%
Endocytosis
33%
In Vitro
16%
Clinical Trial
16%
Sensitization
16%
Peptide Sequence
16%
Transcriptomics
16%
Pharmacokinetic
16%
Flow Cytometry
16%
RNA Sequence
16%
Immunoblotting
16%
Caspase 8
16%
Hematologic Malignancy
16%
Incubation
16%
Acute Myeloid Leukemia
16%
Cancer Cell
16%
Gene Expression Profiling
16%
Proteus Syndrome
16%
Acute Myeloid Leukemia Cell Line
16%
Apoptosis Assay
16%
Lipocortin 5
16%
Chimeric Protein
16%
Burkitt's Lymphoma
16%
Resistant Cell Line
16%
MTS Assay
16%
Classical Hodgkin Lymphoma
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%
Diffuse Large B Cell Lymphoma
100%
Histone Deacetylase Inhibitor
50%
Dynamin
50%
Cytotoxicity
33%
Caspase
33%
Acute Myeloid Leukemia
33%
Death Receptor
33%
Pharmacokinetic
16%
Malignant Neoplasm
16%
Clinical Trial
16%
Receptor Agonist
16%
Flow Cytometry
16%
RNA-Sequencing
16%
Western Blot
16%
Chimeric Protein
16%
Hematologic Malignancy
16%
Caspase 8
16%
Lipocortin 5
16%
Apoptosis Assay
16%
Burkitt's Lymphoma
16%
Classical Hodgkin Lymphoma
16%
Multiple Cancer
16%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factor
100%
Programmed Cell Death
100%
B Cell
100%
Dynamin
27%
Cytotoxicity
18%
Endocytosis
18%
Myeloid
18%
Caspase
18%
Pharmacokinetic
9%
Transcriptomics
9%
Flow Cytometry
9%
Clinical Trial
9%
RNA Sequence
9%
Chimeric Protein
9%
Immunoblotting
9%
Receptor Agonists
9%
Sensitization
9%
Epigenetics
9%
Histone Deacetylase
9%
Cancer Cell
9%
Reprogramming
9%
Caspase 8
9%
Peptide Sequence
9%
Gene Expression Profiling
9%
Lipocortin
9%
Apoptosis Assay
9%